SCHEMBL31069731

SCHEMBL31069731

O=C1c2cc(Br)cnc2OCCN1Cc1cc(OC(F)(F)F)ccc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 1/20 0.49
SCN4A P35499 1/20 0.49
KCNH2 Q12809 1/20 0.49
SCN5A Q14524 1/20 0.49
SCN9A Q15858 1/20 0.49
SCN2A Q99250 1/20 0.49
SCN3A Q9NY46 1/20 0.49
SCN8A Q9UQD0 1/20 0.49
SCN10A Q9Y5Y9 1/20 0.49
ROCK2 O75116 1/20 0.42
ROCK1 Q13464 1/20 0.42
TNIK Q9UKE5 3/20 0.41
ALPL P05186 5/20 0.41
GRM2 Q14416 2/20 0.37
ALKBH1 Q13686 1/20 0.35
CHRM5 P08912 3/20 0.35
RORC P51449 1/20 0.35
MAOA P21397 1/20 0.34
DDR1 Q08345 1/20 0.34
LRRK2 Q5S007 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25380407 1.00 SCN1A (0.49) SCN1ASCN4AKCNH2SCN5ASCN9A
SCHEMBL29714020 0.85 SCN1A (0.38) SCN1ASCN4AKCNH2SCN5ASCN9A
SCHEMBL22470576 0.85 SCN1A (0.38) SCN1ASCN4AKCNH2SCN5ASCN9A
SCHEMBL31118862 0.85 SCN1A (0.55) SCN1ASCN4AKCNH2SCN5ASCN9A
SCHEMBL31069726 0.83 KCNH2 (0.43) SCN1ASCN4AKCNH2SCN5ASCN9A
SCHEMBL31069723 0.83 ALKBH1 (0.37) SCN1ASCN4AKCNH2SCN5ASCN9A
SCHEMBL31069716 0.83 CACNA2D1 (0.45) SCN1ASCN4AKCNH2SCN5ASCN9A
SCHEMBL31069727 0.82 GRM2 (0.37) SCN1ASCN4AKCNH2SCN5ASCN9A
SCHEMBL25438155 0.82 GRM2 (0.37) SCN1ASCN4AKCNH2SCN5ASCN9A
SCHEMBL30483671 0.81 SCN1A (0.41) SCN1ASCN4AKCNH2SCN5ASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118556044-A Fused heterocyclic compound, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2024-08-27 CN disclosed